Factor VIIa inhibitor
View Patent ↗The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rheumatoid arthritis. Processes for preparing these inhibitors are also disclosed.
1. A method of effecting clotting in an individual in need thereof, comprising administering to the individual an isolated compound of Formula Ib:
or a zwitterion thereof or a pharmaceutically acceptable salt thereof;
substantially free of the opposite enantiomer of the compound of Formula Ib.
2. A method of effecting clotting in an individual in need thereof, comprising administering to the individual a pharmaceutical composition comprising:
a. an isolated compound of Formula Ib:
or a zwitterion thereof or a pharmaceutically acceptable salt thereof;
substantially free of the opposite enantiomer of the compound of Formula Ib; and
b. a pharmaceutically acceptable carrier or excipient.
3. The method of claim 2 , wherein the pharmaceutical composition is formulated for parenteral administration.
4. The method of claim 2 , wherein the pharmaceutical composition is formulated for intravenous or subcutaneous administration.
5. The method of claim 2 , wherein the pharmaceutical composition further comprises an additional active ingredient.
6. The method of claim 2 , wherein the pharmaceutical composition comprises water.
7. The method of claim 2 , wherein the pH of the pharmaceutical composition is adjusted to a pharmaceutically acceptable pH.